Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hydroxyurea for Stroke Prevention in Children With Sickle Cell Disease in Sub-Saharan Africa

NCT02675790 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT02675790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02675790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hydroxyurea for Stroke Prevention in Children With Sickle Cell Disease in Sub-Saharan Africa
Lead sponsor
Vanderbilt University Medical Center
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2017
Completion date
March 31, 2020
Enrollment
120 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell anemia, sickle cell disease, stroke